AAHomecare launched two portals to collect end user and family caregiver stories about the real-world impact of policy changes for NIV and continuous glucose monitors (CGM).

It is not uncommon for DME suppliers and sleep labs to work together in the provision of therapeutic equipment to patients who test positive for OSA.

Medtrade exhibitor Fisher & Paykel Healthcare Corp has launched the F&P my820 System into the United States.

VGM Sleep Services has earned accreditation from the Healthcare Quality Association on Accreditation (HQAA).

One meta-study found mortality was 37% lower on average in patients with PAP-treated OSA vs untreated OSA.

With a $1.1 billion settlement reached, the DreamStation difficulties may finally be over for Philips Respironics.